                         SEQUENCE LISTING

<110>  IFOM - Fondazione Istituto FIRC di Oncologia
       Universit degli Studi di Milano
 
<120>  METHODS AND COMPOSITIONS FOR THE TREATMENT OF VASCULAR 
       MALFORMATION

<130>  PCT 126319

<150>  EP14164118.3
<151>  2014-04-10

<160>  19    

<170>  PatentIn version 3.5

<210>  1
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe

<400>  1
gataggaatt attactgccc ttcc                                              24


<210>  2
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe

<400>  2
gacaagaaag cactgttgac c                                                 21


<210>  3
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe

<400>  3
gataggaatt attactgccc ttcc                                              24


<210>  4
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe

<400>  4
gctaccaatc agcttcttag ccc                                               23


<210>  5
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe

<400>  5
ccaaaatttg cctgcattac cggtcgatgc                                        30


<210>  6
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe

<400>  6
atccaggtta cggatatagt                                                   20


<210>  7
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe

<400>  7
cggtgatggt gctgcgttgg a                                                 21


<210>  8
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe

<400>  8
accaccgcac gatagagatt c                                                 21


<210>  9
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe

<400>  9
gcgaagagtt tgtcctcaac c                                                 21


<210>  10
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe

<400>  10
ggagcgggag aaatggatat g                                                 21


<210>  11
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe

<400>  11
aaagtcgctc tgagttgtta t                                                 21


<210>  12
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  forward probe

<400>  12
cgagtccctc cttcgtatgg                                                   20


<210>  13
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  reverse probe

<400>  13
gctctggccg ctcaatca                                                     18


<210>  14
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  reporter sequence probe

<400>  14
ctgatgacgt agaagagtac a                                                 21


<210>  15
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  siRNA oligo target sequence

<400>  15
agacagaccc caaacguaa                                                    19


<210>  16
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  siRNA oligo target sequence

<400>  16
gaaaauggcu ugucgaauu                                                    19


<210>  17
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  siRNA oligo target sequence

<400>  17
agggaaacau cuauaacga                                                    19


<210>  18
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  siRNA oligo target sequence

<400>  18
ccgccaacau cacggucaa                                                    19


<210>  19
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  misc_feature
<222>  (2)..(3)
<223>  Xaa can be any naturally occurring amino acid

<400>  19

Leu Xaa Xaa Leu Leu 
1               5   


